{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:57:17Z","timestamp":1787968637300,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023358","name":"National University of la Plata Faculty of Exact Sciences","doi-asserted-by":"publisher","award":["PPID 2022-2023"],"award-info":[{"award-number":["PPID 2022-2023"]}],"id":[{"id":"10.13039\/501100023358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003947","name":"Universidad Nacional de La Plata","doi-asserted-by":"publisher","award":["PID 2023-2024 X944"],"award-info":[{"award-number":["PID 2023-2024 X944"]}],"id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PUE 0010"],"award-info":[{"award-number":["PUE 0010"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 0144"],"award-info":[{"award-number":["PIP 0144"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP0330"],"award-info":[{"award-number":["PIP0330"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2051"],"award-info":[{"award-number":["PIP 2051"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIBAA 1078"],"award-info":[{"award-number":["PIBAA 1078"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","award":["IISR-103279"],"award-info":[{"award-number":["IISR-103279"]}],"id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijbiomac.2024.138248","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T07:29:17Z","timestamp":1732951757000},"page":"138248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effective encapsulation of therapeutic recombinant enzyme into polymeric nanoparticles as a potential vehicle for lysosomal disease treatment"],"prefix":"10.1016","volume":"285","author":[{"given":"Andrea N.","family":"Crivaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Boztepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Sebasti\u00e1n","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Yamil","family":"Chain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Huck-Iriart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego G.","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n A.","family":"Islan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rozenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.138248_bb0005","article-title":"Lysosomal storage diseases","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0b013e3182057be4","article-title":"Osseous manifestations of adult gaucher disease in the era of enzyme replacement therapy","author":"Deegan","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0020","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2014.02.011","article-title":"Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology","author":"Grabowski","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0030","doi-asserted-by":"crossref","DOI":"10.2147\/CE.S93717","article-title":"Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy","author":"Serratrice","year":"2016","journal-title":"Core Evid."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2011.12.017","article-title":"Velaglucerase alfa for the management of type 1 Gaucher disease","author":"Morris","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0040","series-title":"Velaglucerase Alfa in the Treatment of Gaucher Disease Type 1","author":"Burrow","year":"2011"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0045","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/973231","article-title":"A guided tour of the structural biology of Gaucher disease: acid-\u03b2-glucosidase and saposin C","author":"Lieberman","year":"2011","journal-title":"Enzyme Res."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwp138","article-title":"Characterization of gene-activated human acid-\u03b2-glucosidase: crystal structure, glycan composition, and internalization into macrophages","author":"Brumshtein","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0055","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-016-0387-2","article-title":"Cellular uptake of glucocerebrosidase in Gaucher patients receiving enzyme replacement treatment","author":"Gras-Colomer","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2016.10.008","article-title":"Management goals for type 1 Gaucher disease: an expert consensus document from the European working group on Gaucher disease","author":"Biegstraaten","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0065","article-title":"Assessment of bone vascularization and its role in bone remodeling","author":"L\u00e8 Ne Lafage-Proust","year":"2015","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0070","series-title":"Critical Reviews in Biotechnology","first-page":"447","article-title":"Nanodevices for the immobilization of therapeutic enzymes","volume":"Vol. 36","author":"Bosio","year":"2016"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0075","series-title":"Handb Nanoencapsulation Prep Charact Deliv Saf Nutraceutical Nanocomposites","article-title":"Nanoencapsulation and targeted delivery of different enzymes","author":"Kumar","year":"2023"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0080","article-title":"Polymers as encapsulating agents and delivery vehicles of enzymes","author":"Pereira","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0085","doi-asserted-by":"crossref","DOI":"10.2174\/1389557516666160801111507","article-title":"Liposomal encapsulation enzymes: from medical applications to kinetic characteristics","author":"Jahadi","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12257-014-0327-7","article-title":"Preparation of liposomes containing lysosomal enzymes for therapeutic use","author":"Bang","year":"2014","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0095","series-title":"Liposomes Drug Deliv What, Where, How When to Deliv","article-title":"Liposome stability and integrity","author":"Giannopoulos-Dimitriou","year":"2024"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23074034","article-title":"Comparison between nanoparticle encapsulation and surface loading for lysosomal enzyme replacement therapy","author":"Muntimadugu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0105","doi-asserted-by":"crossref","DOI":"10.2174\/0929867323666160210130608","article-title":"Role of nanotechnology for enzyme replacement therapy in lysosomal diseases. A focus on Gaucher\u2019s disease","author":"Mart\u00edn-Banderas","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1684","article-title":"Nanotechnology-based approaches for treating lysosomal storage disorders, a focus on Fabry disease","author":"Abasolo","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2016.09.074","article-title":"Strategies for delivering bone morphogenetic protein for bone healing","author":"Begam","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201500746","article-title":"\u03b1-Galactosidase-a loaded-nanoliposomes with enhanced enzymatic activity and intracellular penetration","author":"Cabrera","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1401337111","article-title":"Engineered nanomedicine for myeloma and bone microenvironment targeting","author":"Swami","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2020.12.108","article-title":"Protein corona, understanding the nanoparticle-protein interactions and future perspectives: a critical review","author":"Kopac","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2021.01.005","article-title":"Binary medical nanofluids by combination of polymeric Eudragit nanoparticles for vehiculization of tobramycin and resveratrol: antimicrobial, hemotoxicity and protein corona studies","author":"Toledo","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/21691401.2019.1626414","article-title":"Bioconjugation as a smart immobilization approach for \u03b1-amylase enzyme using stimuli-responsive Eudragit-L100 polymer: a robust biocatalyst for applications in pharmaceutical industry","author":"Abdel-Mageed","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0150","first-page":"1085","article-title":"Nanoencapsulated laccases obtained by double-emulsion technique. Effects on enzyme activity pH-dependence and stability","volume":"10","author":"Chong-Cerda","year":"2020","journal-title":"Catal"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110917","article-title":"Incorporation of lysozyme into a mucoadhesive electrospun patch for rapid protein delivery to the oral mucosa","author":"Edmans","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082045","article-title":"Cytotoxic screening and enhanced anticancer activity of Lippia alba and Clinopodium nepeta essential oils-loaded biocompatible lipid nanoparticles against lung and colon cancer cells","author":"Rodenak-Kladniew","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0165","first-page":"158","article-title":"Leukocyte \u03b2-glucosidase in homozygotes and heterozygotes for Gaucher disease","volume":"32","author":"Raghavan","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/stem.1732","article-title":"Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddx442","article-title":"Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition","author":"Panicker","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0185","article-title":"Zeta potential measurement as a diagnostic tool in enzyme immobilisation","author":"Schultz","year":"2008","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0190","doi-asserted-by":"crossref","DOI":"10.1107\/S0021889806004699","article-title":"ATSAS 2.1, a program package for small-angle scattering data analysis","author":"Konarev","year":"2006","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0195","doi-asserted-by":"crossref","DOI":"10.1107\/S0021889809000338","article-title":"DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering","author":"Franke","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2023.04.004","article-title":"Cellular proteins act as surfactants to control the interfacial behavior and function of biological condensates","author":"Wang","year":"2023","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0205","article-title":"Modulating lysosomal pH: a molecular and nanoscale materials design perspective","author":"Zeng","year":"2020","journal-title":"J. Life Sci. (Westlake Village, Calif)."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15290-z","article-title":"Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2005.07.009","article-title":"Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model","author":"Lamghari","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0220","series-title":"Lysosomal Storage, Impaired Autophagy and Innate Immunity in Gaucher and Parkinson\u2019s Diseases: Insights for Drug Discovery","author":"Kinghorn","year":"2024"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011063","article-title":"Autophagic dysfunction and gut microbiota dysbiosis cause chronic immune activation in a Drosophila model of Gaucher disease","author":"Atilano","year":"2023","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2014.05.003","article-title":"Osteoblast and osteocyte: games without frontiers","author":"Capulli","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0235","article-title":"Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis","author":"Crivaro","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2017.03.021","article-title":"Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy","author":"Rodenak-Kladniew","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0245","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2147\/IJN.S44393","article-title":"Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration","volume":"8","author":"Gu","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.00166","article-title":"Recent advances in understanding the protein corona of nanoparticles and in the formulation of \u201cstealthy\u201d nanomaterials","author":"Rampado","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0255","doi-asserted-by":"crossref","DOI":"10.3762\/bjnano.10.101","article-title":"Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles","author":"Partikel","year":"2019","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114464","article-title":"Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders","author":"Del Grosso","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200384","article-title":"Targeted enzymatic VLP-nanoreactors with \u03b2-glucocerebrosidase activity as potential enzyme replacement therapy for Gaucher\u2019s disease","author":"Chauhan","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2024.138248_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102735","article-title":"Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease","author":"Sun","year":"2020","journal-title":"EBioMedicine"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024090597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024090597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T02:06:15Z","timestamp":1738461975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024090597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"alternative-id":["S0141813024090597"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138248","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective encapsulation of therapeutic recombinant enzyme into polymeric nanoparticles as a potential vehicle for lysosomal disease treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138248"}}